75 results
Page 3 of 4
8-K
EX-99
mxjkxw pw6x9x
19 May 20
Cue Biopharma Reports First Quarter 2020 Results, Updates ofCUE-101 Phase 1 Dose Escalation Study and Recent Business Highlights
4:06pm
424B5
5btvrvb6i2vcqj14ws
27 Mar 20
Prospectus supplement for primary offering
4:50pm
8-K
EX-99
xtqvdzx p21iftf
17 Mar 20
Cue Biopharma Reports Fourth Quarter and Full Year 2019 Financial Results
4:23pm
8-K
EX-10.1
94nrds xz
10 Feb 20
Entry into a Material Definitive Agreement
4:01pm
424B5
p1g s8h1d
25 Nov 19
Prospectus supplement for primary offering
5:28pm
8-K
EX-99
ove92 o0om
12 Nov 19
Cue Biopharma Reports Third Quarter 2019 Financial Results
4:05pm
8-K
EX-10.2
ej2hyc49famurbu
7 Oct 19
Entry into a Material Definitive Agreement
4:42pm
8-K
EX-10.1
g1otojdmqm824lb60ol5
7 Oct 19
Entry into a Material Definitive Agreement
4:42pm
424B5
ma87xnhlf2w6cmq9ck
5 Jun 19
Prospectus supplement for primary offering
8:49am
PRE 14A
oqwq0h
30 May 19
Preliminary proxy
12:00am